{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:14:56Z","timestamp":1792800896256,"version":"4.5.0"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7794-26","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:11:48Z","timestamp":1790633508000},"source":"Crossref","is-referenced-by-count":1,"title":["Rituximab-Induced Crohn\u2019s Disease-like Colitis Following Treatment for Post-transplant Lymphoproliferative Disorder in Chronic Active Epstein-Barr Virus Infection: A Case Report"],"prefix":"10.2169","author":[{"given":"Kanako","family":"Higaki","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Okabe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Fuyuno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Onoyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Namikawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kitamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Bamba","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kyoto University Graduate School of Medicine Faculty of Medicine, Japan"},{"name":"Department of Hematology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyoshi","family":"Yoshinaga","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kyoto University Graduate School of Medicine Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kyoto University Graduate School of Medicine Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Seno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S. Post-transplant lymphoproliferative disorders. Nat Rev Dis Primers 2: 15088, 2016.","DOI":"10.1038\/nrdp.2015.88"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Trappe R, Oertel S, Leblond V, et al. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol 13: 196-206, 2012.","DOI":"10.1016\/S1470-2045(11)70300-X"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Eckmann JD, Chedid V, Quinn KP, Bonthu N, Nehra V, Raffals LE. De novo colitis associated with rituximab in 21 patients at a tertiary center. Clin Gastroenterol Hepatol 18: 252-253, 2020.","DOI":"10.1016\/j.cgh.2019.03.027"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Quesada-Sim\u00f3 A, Garrido-Mar\u00edn A, Nos P, Gil-Perot\u00edn S. Impact of anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with de novo intestinal bowel disease in multiple sclerosis: a review. Front Pharmacol 14: 1186016, 2023.","DOI":"10.3389\/fphar.2023.1186016"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sawada A, Inoue M. Hematopoietic stem cell transplantation for the treatment of Epstein-Barr virus-associated T- or NK-cell lymphoproliferative diseases and associated disorders. Front Pediatr 6: 334, 2018.","DOI":"10.3389\/fped.2018.00334"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Morita K, Shibano T, Maekawa K, et al. Crohn\u2019s disease following rituximab treatment in a patient with refractory nephrotic syndrome. CEN Case Rep 8: 55-60, 2018.","DOI":"10.1007\/s13730-018-0364-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Varma P, Falconer J, Aga A, Prince HM, Pianko S. Rituximab-induced Crohn\u2019s disease. Scand J Gastroenterol 52: 606-608, 2017.","DOI":"10.1080\/00365521.2017.1280530"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tsuzuki Y, Shiomi R, Ashitani K, et al. Rituximab-induced ileocolitis in a patient with gastric MALToma: a case report and literature review. Intern Med 60: 731-738, 2021.","DOI":"10.2169\/internalmedicine.5119-20"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Martinez Perez P, Hanna L, Jaynes E, Gwiggner M. Infliximab rescue therapy in a case of severe granulomatous colitis associated with rituximab use. BMJ Case Rep 17: e257729, 2024.","DOI":"10.1136\/bcr-2023-257729"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bhalme M, Hayes S, Norton A, Lal S, Chinoy H, Paine P. Rituximab-associated colitis. Inflamm Bowel Dis 19: E41-43, 2013.","DOI":"10.1002\/ibd.22963"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Goetz M, Atreya R, Ghalibafian M, Galle PR, Neurath MF. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 13: 1365-1368, 2007.","DOI":"10.1002\/ibd.20215"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. El Fassi D, Nielsen CH, Kjeldsen J, Clemmensen O, Heged\u00fcs L. Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves\u2019 disease. Gut 57: 714-715, 2008.","DOI":"10.1136\/gut.2007.138305"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ardelean DS, Gonska T, Wires S, et al. Severe ulcerative colitis after rituximab therapy. Pediatrics 126: e243-246, 2010.","DOI":"10.1542\/peds.2009-3395"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Blombery P, Prince HM, Levinson M, Pianko S, Maxwell E, Bhathal P. Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphoma. J Clin Oncol 29: e110-112, 2011.","DOI":"10.1200\/JCO.2010.31.8899"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fraser D, Boyle S, Amft N. Perianal Crohn disease after treatment with rituximab for active granulomatosis with polyangiitis. J Rheumatol 43: 2199-2200, 2016.","DOI":"10.3899\/jrheum.160456"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shahmohammadi S, Sahraian MA, Shahmohammadi A, Doosti R, Zare-Mirzaie A, Naser Moghadasi A. A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review. Mult Scler Relat Disord 22: 22-26, 2018.","DOI":"10.1016\/j.msard.2018.02.030"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Shankar U, Vijayasekar K, Bansal R, Walfish A. Treatment of rituximab-induced Crohn\u2019s disease with ustekinumab induction and long-term maintenance of remission. Inflamm Bowel Dis 26: e3, 2020.","DOI":"10.1093\/ibd\/izz270"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Cavalcanti E, Armentano R, Lolli I. Crohn\u2019s disease following rituximab treatment for follicular lymphoma in a patient with synchronous gastric signet ring cells carcinoma: a case report and literature review. Cancer Res Treat 52: 1291-1295, 2020.","DOI":"10.4143\/crt.2020.406"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shi K, Fu M, Xia W, Zhang P, Gao C, Xia Z. Crohn\u2019s disease after multiple doses of rituximab treatment in a child with refractory nephrotic syndrome and an ATG2A mutation: a case report. Front Pediatr 12: 1464757, 2024.","DOI":"10.3389\/fped.2024.1464757"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Li XJ, Fung BM, Kumar R. Successful treatment of rituximab-induced Crohn\u2019s disease with ustekinumab. ACG Case Rep J 11: e01403, 2024.","DOI":"10.14309\/crj.0000000000001403"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yokoyama Y, Kurumi H, Nakase H. Rituximab-associated colitis mimicking ulcerative colitis. Dig Endosc 37: 295-295, 2025.","DOI":"10.1111\/den.14982"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Alvarado-Hern\u00e1ndez RA, Reyes-Morales JM, Escandon-Espinoza YM, Lopez Garcia KD, Ayuso-Diaz VM, Moreno-Enriquez A. Endoscopic and histopathologic findings of rituximab-associated colitis in a patient with scleroderma. Cureus 17: e88780, 2025.","DOI":"10.7759\/cureus.88780"},{"key":"23","unstructured":"23. Lipka S, Katz S, Crawford JM. Fulminant colitis following rituximab therapy. Gastroenterol Hepatol (N Y) 12: 58-60, 2016."},{"key":"24","unstructured":"24. Nakase H. The characteristics of intestinal lesions of familial Mediterranean fever gene-related enterocolitis. Gastroenterological Endoscopy 61: 2455-2465, 2019."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yin X, Tian F, Wu B, Xu T. Interventions for reducing inflammation in familial Mediterranean fever. Cochrane Database Syst Rev 2022: CD010893, 2022.","DOI":"10.1002\/14651858.CD010893.pub4"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Stewart S, Yang KCK, Atkins K, Dalbeth N, Robinson PC. Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther 22: 28, 2020.","DOI":"10.1186\/s13075-020-2120-7"},{"key":"27","unstructured":"27. Saegusa Y, Endo Y. Rituximab-induced Crohn\u2019s disease-like lesions. IBD Research 14: 268-273, 2020."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Barberio B, Gracie DJ, Black CJ, Ford AC. Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn\u2019s disease: systematic review and network meta-analysis. Gut 72: 264-274, 2023.","DOI":"10.1136\/gutjnl-2022-328052"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Cholapranee A, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN. Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn\u2019s disease and ulcerative colitis controlled trials. Aliment Pharmacol Ther 45: 1291-1302, 2017.","DOI":"10.1111\/apt.14030"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Zhou D, Li C, Huang D, et al. Reduced-dose donor lymphocyte infusion is a viable therapeutic strategy for Epstein-Barr virus-related post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation: a single-center experience. Clin Exp Med 25: 152, 2025.","DOI":"10.1007\/s10238-025-01685-0"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7794-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:29:58Z","timestamp":1790998198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7794-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":30,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7794-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7794-26"}}